Genotypic drug resistance interpretation algorithms display high levels of discordance when applied to non-B strains from HIV-1 naive and treated patients

This publication has 22 references indexed in Scilit:

• Mutation D30N Is Not Preferentially Selected by Human Immunodeficiency Virus Type 1 Subtype C in the Development of Resistance to Nelfinavir
  Antimicrobial Agents and Chemotherapy, 2004
• Comparative evaluation of three computerized algorithms for prediction of antiretroviral susceptibility from HIV type 1 genotype
  Journal of Antimicrobial Chemotherapy, 2004
• Genetic diversity of HIV in Africa
  AIDS, 2003
• Antiretroviral Drug Resistance Testing in Adults Infected with Human Immunodeficiency Virus Type 1: 2003 Recommendations of an International AIDS Society–USA Panel
  Clinical Infectious Diseases, 2003
• Variable Prediction of Antiretroviral Treatment Outcome by Different Systems for Interpreting Genotypic Human Immunodeficiency Virus Type 1 Drug Resistance
  The Journal of Infectious Diseases, 2003
• A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors
  AIDS, 2003
• Genetic Divergence of Human Immunodeficiency Virus Type 1 Ethiopian Clade C Reverse Transcriptase (RT) and Rapid Development of Resistance against Nonnucleoside Inhibitors of RT
  Antimicrobial Agents and Chemotherapy, 2002
• Genotypic Testing for Human Immunodeficiency Virus Type 1 Drug Resistance
  Clinical Microbiology Reviews, 2002
• Secondary Mutations in the Protease Region of Human Immunodeficiency Virus and Virologic Failure in Drug‐Naive Patients Treated with Protease Inhibitor–Based Therapy
  The Journal of Infectious Diseases, 2001
• HIV-1 Nomenclature Proposal
  Science, 2000